Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Perfusion
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Myers, G. J
Right arrow Articles by Hirsch, G. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Myers, G. J
Right arrow Articles by Hirsch, G. M
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Double valve replacement in a patient with anticardiolipin antibody syndrome

Gerard J Myers

Department of Cardiovascular Surgery, QEII Health Sciences Center, Halifax, Nova Scotia, edit{at}ns.sympatico.ca

Gregory M Hirsch

Department of Cardiovascular Surgery, QEII Health Sciences Center, Halifax, Nova Scotia

Cardiopulmonary bypass (CPB) was used during the replacement of the aortic and mitral valves in a 43-year-old female patient. The case was complicated by the presence of a rare hypercoagulable condition called anticardiolipin (antiphospholipid) antibody syndrome. The course of bypass was uneventful and the patient was released from the intensive care unit on the first postoperative day. CPB in the presence of anticardiolipin antibodies is an unusual situation that requires diligent hematological monitoring. Since 1989 there have been only 14 reported cases of these antibodies and cardiopulmonary bypass. Eight of these have involved valve replacements.

Perfusion, Vol. 14, No. 5, 397-401 (1999)
DOI: 10.1177/026765919901400512
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Eur. J. Cardiothorac. Surg.Home page
H. Gorki, V. Malinovski, and R. D.L. Stanbridge
The antiphospholipid syndrome and heart valve surgery
Eur. J. Cardiothorac. Surg., February 1, 2008; 33(2): 168 - 181.
[Abstract] [Full Text] [PDF]

Home page
 Asian Cardiovasc. Thorac. Ann.Home page
M. M Maddali and M. J Albahrani
Lupus Anticoagulant and Off-pump Coronary Bypass: Dilemma of Anticoagulation
Asian Cardiovasc Thorac Ann, June 1, 2007; 15(3): 246 - 248.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
P. Massoudy, S. M. Cetin, M. Thielmann, P. Kienbaum, J. A. Piotrowski, G. Marggraf, C. Specker, and H. Jakob
Antiphospholipid syndrome in cardiac surgery--an underestimated coagulation disorder?
Eur. J. Cardiothorac. Surg., July 1, 2005; 28(1): 133 - 137.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
R. I. P. Dornan
Acute postoperative biventricular failure associated with antiphospholipid antibody syndrome
Br. J. Anaesth., May 1, 2004; 92(5): 748 - 754.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
Y. Berkun, A. Elami, K. Meir, D. Mevorach, and Y. Naparstek
Increased morbidity and mortality in patients with antiphospholipid syndrome undergoing valve replacement surgery
J. Thorac. Cardiovasc. Surg., February 1, 2004; 127(2): 414 - 420.
[Abstract] [Full Text] [PDF]